Follow
Tamás Ferenci
Tamás Ferenci
Associate professor, Óbuda University
Verified email at nik.uni-obuda.hu - Homepage
Title
Cited by
Cited by
Year
Trends in major lower limb amputation related to peripheral arterial disease in Hungary: a nationwide study (2004–2012)
E Kolossvary, T Ferenci, T Kovats, L Kovács, Z Jarai, G Menyhei, K Farkas
European Journal of Vascular and Endovascular Surgery 50 (1), 78-85, 2015
792015
Non‐nutritive sweeteners for diabetes mellitus
S Lohner, DK de Gaudry, I Toews, T Ferenci, JJ Meerpohl
Cochrane Database of Systematic Reviews, 2020
712020
Early phase of the COVID-19 outbreak in Hungary and post-lockdown scenarios
G Röst, FA Bartha, N Bogya, P Boldog, A Dénes, T Ferenci, KJ Horváth, ...
Viruses 12 (7), 708, 2020
702020
The issue of plasma asymmetric dimethylarginine reference range–A systematic review and meta-analysis
B Németh, Z Ajtay, L Hejjel, T Ferenci, Z Ábrám, E Murányi, I Kiss
PLoS One 12 (5), e0177493, 2017
552017
Different approaches to quantify years of life lost from COVID-19
T Ferenci
European Journal of Epidemiology 36 (6), 589-597, 2021
432021
Can Google Trends data improve forecasting of Lyme disease incidence?
M Kapitány‐Fövény, T Ferenci, Z Sulyok, J Kegele, H Richter, ...
Zoonoses and public health 66 (1), 101-107, 2019
422019
Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6 …
A Kocsis, T Takács, C Jeney, Z Schaff, R Koiss, B Járay, G Sobel, K Pap, ...
International Journal of Cancer 140 (5), 1119-1133, 2017
412017
RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine
T Ferenci, B Sarkadi
BMC Infectious Diseases 22 (1), 87, 2022
39*2022
Quantitative impact of direct, personal feedback on hand hygiene technique
A Lehotsky, L Szilágyi, T Ferenci, L Kovács, R Pethes, G Wéber, ...
Journal of Hospital Infection 91 (1), 81-84, 2015
392015
Tumor dynamics modeling based on formal reaction kinetics
DA Drexler, T Ferenci, A Lovrics, L Kovács
Acta Polytechnica Hungarica 16 (10), 31-44, 2019
382019
Predicting body fat percentage from anthropometric and laboratory measurements using artificial neural networks
T Ferenci, L Kovacs
Applied Soft Computing 67, 834-839, 2018
382018
Google Trends Data and COVID‐19 in Europe: Correlations and model enhancement are European wide
M Sulyok, T Ferenci, M Walker
Transboundary and Emerging Diseases 68 (4), 2610-2615, 2021
372021
A koronavírus okozta COVID–19-pandémia. Korábbi tapasztalatok és tudományos evidenciák 2020. március végén
A Váradi, T Ferenci, A Falus
Orvosi hetilap 161 (17), 644-651, 2020
36*2020
The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes
T Ferenci, A Körner, L Kovács
Diabetes research and clinical practice 108 (1), 38-44, 2015
362015
Comparing machine learning and regression models for mortality prediction based on the Hungarian Myocardial Infarction Registry
P Piros, T Ferenci, R Fleiner, P Andréka, H Fujita, L Főző, L Kovács, ...
Knowledge-Based Systems 179, 1-7, 2019
352019
Experimental data-driven tumor modeling for chemotherapy
DA Drexler, T Ferenci, A Füredi, G Szakács, L Kovács
IFAC-PapersOnLine 53 (2), 16245-16250, 2020
322020
Chickenpox cases in Hungary: a benchmark dataset for spatiotemporal signal processing with graph neural networks
B Rozemberczki, P Scherer, O Kiss, R Sarkar, T Ferenci
arXiv preprint arXiv:2102.08100, 2021
302021
Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study
M Sulyok, M Makara, Z Rupnik, T Ferenci, E Újhelyi, L Kormos, Z Gerlei, ...
European journal of gastroenterology & hepatology 27 (6), 679-685, 2015
282015
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
M Blöndal, T Ainla, J Eha, P Lõiveke, T Marandi, A Saar, G Veldre, ...
European Heart Journal-Quality of Care and Clinical Outcomes 8 (3), 307-314, 2022
242022
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis–experiences from a single center
K Farkas, M Rutka, T Ferenci, F Nagy, A Balint, R Bor, A Milassin, ...
Expert Opinion on Biological Therapy 17 (11), 1325-1332, 2017
242017
The system can't perform the operation now. Try again later.
Articles 1–20